[ { "report_key": "2026:q1", "period_label": "2026 Q1", "date": "2026-05-12", "title": "Kvartalsrapport Q1 2026", "original_title": "Delårsrapport januari - mars 2026", "category": "Interimsrapport", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://view.news.eu.nasdaq.com/view?id=bd8bfd1621c14ce7d37a887abba216820&lang=sv&src=listed", "language": "sv", "report_type": "interim-report", "fiscal_year": 2026, "quarter": "q1", "documents": [ { "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026", "title": "Kvartalsrapport Q1 2026", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a33ca736461d70a771af7251d5d201e1f", "date": "2026-05-12", "period": "2026-q1", "form_type": "interim-report", "report_key": "2026:q1", "filename": "05111212.pdf", "text_chars": 40158, "sha256": "eec9efb8ab54a89d5132de2b301defe81e5efcbe56128a634b54614089bd85f6", "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026", "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026", "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt", "parts": [ { "number": 1, "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html", "chars": 40158 } ] } ], "alternatives": [] }, { "report_key": "2025:annual", "period_label": "2025 Årsredovisning", "date": "2026-04-17", "title": "Årsredovisning 2025", "original_title": "Moberg Pharmas årsredovisning för räkenskapsåret 2025 offentliggjord", "category": "Övrig information som ska lämnas enligt börsens regler", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://view.news.eu.nasdaq.com/view?id=b46d473bd96ac88a93171ea16ac123e5d&lang=sv&src=listed", "language": "sv", "report_type": "annual-report", "fiscal_year": 2025, "quarter": "annual", "documents": [ { "doc_id": "nasdaq-nordic-arsredovisning-2025", "title": "Årsredovisning 2025", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a0917f6991d6c3be300cd92421349d4be", "date": "2026-04-17", "period": "2025-annual", "form_type": "annual-report", "report_key": "2025:annual", "filename": "04169804.pdf", "text_chars": 236130, "sha256": "40d505db6959517a590cdf9507121369e549bd7c7964ac2a2613ac4f99c0d832", "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2025", "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2025", "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt", "parts": [ { "number": 1, "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2025/part-001.html", "chars": 177675 }, { "number": 2, "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2025/part-002.html", "chars": 58453 } ] } ], "alternatives": [] }, { "report_key": "2025:q4", "period_label": "2025 Q4", "date": "2026-02-17", "title": "Kvartalsrapport Q4 2025", "original_title": "Moberg Pharma bokslutskommuniké 2025", "category": "Bokslutskommuniké", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://view.news.eu.nasdaq.com/view?id=b40c3e0001360ece8761995aaa378e08a&lang=sv&src=listed", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2025, "quarter": "q4", "documents": [ { "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025", "title": "Kvartalsrapport Q4 2025", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/acc11051b4d2bceb57dbf5b2a9ba1ff69", "date": "2026-02-17", "period": "2025-q4", "form_type": "year-end-report", "report_key": "2025:q4", "filename": "02161823.pdf", "text_chars": 42700, "sha256": "5669c83cdc53f4b22974c53dbab55ceb39718ea34c3a741e04baba6cbc97af06", "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025", "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025", "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt", "parts": [ { "number": 1, "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html", "chars": 42700 } ] } ], "alternatives": [] }, { "report_key": "2025:q3", "period_label": "2025 Q3", "date": "2025-11-11", "title": "Kvartalsrapport Q3 2025", "original_title": "Moberg Pharmas delårsrapport januari - september 2025", "category": "Interimsrapport", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://view.news.eu.nasdaq.com/view?id=b25c4bde78c49d222f408727bfd59e045&lang=sv&src=listed", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q3", "documents": [ { "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025", "title": "Kvartalsrapport Q3 2025", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a178f416752247c2e0c187254b6798490", "date": "2025-11-11", "period": "2025-q3", "form_type": "interim-report", "report_key": "2025:q3", "filename": "11107927.pdf", "text_chars": 46645, "sha256": "7e4e9819200e47890c19f17e84f6d0d6b47e7a5f6eccada7010068b139befc67", "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025", "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025", "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt", "parts": [ { "number": 1, "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html", "chars": 46645 } ] } ], "alternatives": [] }, { "report_key": "2025:q2", "period_label": "2025 Q2", "date": "2025-08-12", "title": "Kvartalsrapport Q2 2025", "original_title": "Delårsrapport januari - juni 2025", "category": "Halvårsrapport", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://view.news.eu.nasdaq.com/view?id=b80d2e318ec7fd7fed0b95625c47856fa&lang=sv&src=listed", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q2", "documents": [ { "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025", "title": "Kvartalsrapport Q2 2025", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/ac241e37e905facaca03e613f2fe29308", "date": "2025-08-12", "period": "2025-q2", "form_type": "interim-report", "report_key": "2025:q2", "filename": "08119244.pdf", "text_chars": 42376, "sha256": "73b37b43414bf55370ccc87264a3b665f50ee25abe61b05a9700794d7fffcce8", "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025", "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025", "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt", "parts": [ { "number": 1, "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html", "chars": 42376 } ] } ], "alternatives": [] }, { "report_key": "2025:q1", "period_label": "2025 Q1", "date": "2025-05-13", "title": "Kvartalsrapport Q1 2025", "original_title": "Moberg Pharmas delårsrapport januari - mars 2025", "category": "Interimsrapport", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://view.news.eu.nasdaq.com/view?id=bd6c84ce0c3c9ee34fdd221209aed6946&lang=sv&src=listed", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q1", "documents": [ { "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025", "title": "Kvartalsrapport Q1 2025", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a53a15141ad43e9c9a9b3d1313756c139", "date": "2025-05-13", "period": "2025-q1", "form_type": "interim-report", "report_key": "2025:q1", "filename": "05120994.pdf", "text_chars": 40066, "sha256": "5f81368e9e8cb83ef48f8c90fb48c0b3bb319547a31c40892f0a3554a031f960", "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025", "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025", "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt", "parts": [ { "number": 1, "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html", "chars": 40066 } ] } ], "alternatives": [] }, { "report_key": "2024:annual", "period_label": "2024 Årsredovisning", "date": "2025-04-11", "title": "Årsredovisning 2024", "original_title": "Moberg Pharmas årsredovisning för räkenskapsåret 2024 offentliggjord", "category": "Bokslut och Verksamhetsberättelse", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://view.news.eu.nasdaq.com/view?id=b0436a81616efdca7b2ca3db153e05822&lang=sv&src=listed", "language": "sv", "report_type": "annual-report", "fiscal_year": 2024, "quarter": "annual", "documents": [ { "doc_id": "nasdaq-nordic-arsredovisning-2024", "title": "Årsredovisning 2024", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a49c5138d6bfe58b2666822812b59f4cc", "date": "2025-04-11", "period": "2024-annual", "form_type": "annual-report", "report_key": "2024:annual", "filename": "04105917.pdf", "text_chars": 237739, "sha256": "952c67c09b3a817cc9600b274370a0720b40aed9751b45fc8f8343d41f6b3342", "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2024", "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2024", "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt", "parts": [ { "number": 1, "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2024/part-001.html", "chars": 179289 }, { "number": 2, "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2024/part-002.html", "chars": 58448 } ] } ], "alternatives": [] }, { "report_key": "2024:q4", "period_label": "2024 Q4", "date": "2025-02-11", "title": "Kvartalsrapport Q4 2024", "original_title": "Moberg Pharmas bokslutskommuniké 2024", "category": "Bokslutskommuniké", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://view.news.eu.nasdaq.com/view?id=baf90e9b2c925e7baab310cdfa38ccc32&lang=sv&src=listed", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2024, "quarter": "q4", "documents": [ { "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024", "title": "Kvartalsrapport Q4 2024", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a49d7fcb0776498422b629a0d11658605", "date": "2025-02-11", "period": "2024-q4", "form_type": "year-end-report", "report_key": "2024:q4", "filename": "02104805.pdf", "text_chars": 45172, "sha256": "23d6c80cd1b24799649963b2004f5e86f8e0fc2580591994c7a4dffaa2b55c4e", "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024", "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024", "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt", "parts": [ { "number": 1, "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html", "chars": 45172 } ] } ], "alternatives": [] }, { "report_key": "2024:q3", "period_label": "2024 Q3", "date": "2024-11-12", "title": "Kvartalsrapport Q3 2024", "original_title": "Moberg Pharmas delårsrapport januari - september 2024", "category": "Interimsrapport", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://view.news.eu.nasdaq.com/view?id=be716cc5324ebea79369e3fdfdcaa8de5&lang=sv&src=listed", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q3", "documents": [ { "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024", "title": "Kvartalsrapport Q3 2024", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a80f1a2120999595c11908852743cde4c", "date": "2024-11-12", "period": "2024-q3", "form_type": "interim-report", "report_key": "2024:q3", "filename": "11115568.pdf", "text_chars": 46994, "sha256": "605be590ea4094ba24a78272e651a3962e214d36b253761bc65ef6417ce9aaa9", "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024", "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024", "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt", "parts": [ { "number": 1, "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html", "chars": 46994 } ] } ], "alternatives": [] }, { "report_key": "2024:q2", "period_label": "2024 Q2", "date": "2024-08-13", "title": "Kvartalsrapport Q2 2024", "original_title": "Moberg Pharmas delårsrapport januari - juni 2024", "category": "Interimsrapport", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://view.news.eu.nasdaq.com/view?id=bc9580d8f46241b87364a8fc36a4fd081&lang=sv&src=listed", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q2", "documents": [ { "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024", "title": "Kvartalsrapport Q2 2024", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/ad8c9de2d124edc7dc67a43c48400493d", "date": "2024-08-13", "period": "2024-q2", "form_type": "interim-report", "report_key": "2024:q2", "filename": "08124063.pdf", "text_chars": 42791, "sha256": "4434f8270a18cbbdc489caf4ade80d572d66aceaf88d6372284070856e0f8647", "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024", "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024", "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt", "parts": [ { "number": 1, "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html", "chars": 42791 } ] } ], "alternatives": [] }, { "report_key": "2024:q1", "period_label": "2024 Q1", "date": "2024-05-07", "title": "Kvartalsrapport Q1 2024", "original_title": "Moberg Pharmas delårsrapport januari - mars 2024", "category": "Interimsrapport", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://view.news.eu.nasdaq.com/view?id=ba510d2000cd66d39f964a1ac53f4cf53&lang=sv&src=listed", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q1", "documents": [ { "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024", "title": "Kvartalsrapport Q1 2024", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/ac4858f04198212185bf639dd1ab14e12", "date": "2024-05-07", "period": "2024-q1", "form_type": "interim-report", "report_key": "2024:q1", "filename": "05064576.pdf", "text_chars": 39027, "sha256": "191531dfa0611531ab7b62a7617f4498806249ce5b012d7f92d420b336202034", "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2024", "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2024", "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt", "parts": [ { "number": 1, "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html", "chars": 39027 } ] } ], "alternatives": [] }, { "report_key": "2023:annual", "period_label": "2023 Årsredovisning", "date": "2024-04-12", "title": "Årsredovisning 2023", "original_title": "Moberg Pharmas årsredovisning för räkenskapsåret 2023 offentliggjord", "category": "Bokslut och Verksamhetsberättelse", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://view.news.eu.nasdaq.com/view?id=b96d30a7261becb4fa9bce4714dffd517&lang=sv&src=listed", "language": "sv", "report_type": "annual-report", "fiscal_year": 2023, "quarter": "annual", "documents": [ { "doc_id": "nasdaq-nordic-arsredovisning-2023", "title": "Årsredovisning 2023", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/aa992845d56c11ed656a9e84a2417670a", "date": "2024-04-12", "period": "2023-annual", "form_type": "annual-report", "report_key": "2023:annual", "filename": "04110439.pdf", "text_chars": 236217, "sha256": "35d5862def1400adb3c8886f003cc0bdadb010b6eb94798b112c55125e05e461", "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2023", "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2023", "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt", "parts": [ { "number": 1, "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2023/part-001.html", "chars": 178691 }, { "number": 2, "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2023/part-002.html", "chars": 57524 } ] } ], "alternatives": [] }, { "report_key": "2023:q4", "period_label": "2023 Q4", "date": "2024-02-13", "title": "Kvartalsrapport Q4 2023", "original_title": "Bokslutskommuniké 2023", "category": "Bokslutskommuniké", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://view.news.eu.nasdaq.com/view?id=bffbd5de14e3656e097b40015e2307764&lang=sv&src=listed", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2023, "quarter": "q4", "documents": [ { "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023", "title": "Kvartalsrapport Q4 2023", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a18b0f28e1473af0169520a46183acb6d", "date": "2024-02-13", "period": "2023-q4", "form_type": "year-end-report", "report_key": "2023:q4", "filename": "02126814.pdf", "text_chars": 41832, "sha256": "2ea9b564a8142e5b48190c78bd69c156624a7f2a277a8562b2733aa12446a2e4", "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2023", "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2023", "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt", "parts": [ { "number": 1, "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html", "chars": 41832 } ] } ], "alternatives": [] }, { "report_key": "2023:q3", "period_label": "2023 Q3", "date": "2023-11-07", "title": "Kvartalsrapport Q3 2023", "original_title": "Moberg Pharmas delårsrapport januari - september 2023", "category": "Interimsrapport", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://view.news.eu.nasdaq.com/view?id=b20e28bb9d5e601dcc82671e76432a626&lang=sv&src=listed", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q3", "documents": [ { "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023", "title": "Kvartalsrapport Q3 2023", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a13541e6792fa90aacea1c7c49dcc5d72", "date": "2023-11-07", "period": "2023-q3", "form_type": "interim-report", "report_key": "2023:q3", "filename": "11069198.pdf", "text_chars": 44269, "sha256": "f5e96900782a0e062251b8a70fa43050da7f0e4490216e0158a22d679d1f8077", "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2023", "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2023", "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt", "parts": [ { "number": 1, "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html", "chars": 44269 } ] } ], "alternatives": [] }, { "report_key": "2023:q2", "period_label": "2023 Q2", "date": "2023-08-03", "title": "Kvartalsrapport Q2 2023", "original_title": "Moberg Pharmas delårsrapport januari - juni 2023", "category": "Interimsrapport", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://view.news.eu.nasdaq.com/view?id=b1082d35e4d8460c273e1caea48cac238&lang=sv&src=listed", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q2", "documents": [ { "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023", "title": "Kvartalsrapport Q2 2023", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a3ace2efddca7c5f5f301e7a02b74dff4", "date": "2023-08-03", "period": "2023-q2", "form_type": "interim-report", "report_key": "2023:q2", "filename": "08021298.pdf", "text_chars": 40267, "sha256": "4b01c41ebadd918f34d97d01cf82049932396e2eadaa2fc1a503995ff3c2f3d0", "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2023", "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2023", "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt", "parts": [ { "number": 1, "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html", "chars": 40267 } ] } ], "alternatives": [] }, { "report_key": "2023:q1", "period_label": "2023 Q1", "date": "2023-05-09", "title": "Kvartalsrapport Q1 2023", "original_title": "Moberg Pharmas delårsrapport januari - mars 2023", "category": "Interimsrapport", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://view.news.eu.nasdaq.com/view?id=b5d0b7483d8b050ed5339da2cc91f932c&lang=sv&src=listed", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q1", "documents": [ { "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023", "title": "Kvartalsrapport Q1 2023", "source": "Nasdaq Nordic", "source_class": "nasdaq-report", "source_url": "https://attachment.news.eu.nasdaq.com/a48aae1f357bb375199230e6b5ed706ad", "date": "2023-05-09", "period": "2023-q1", "form_type": "interim-report", "report_key": "2023:q1", "filename": "05084027.pdf", "text_chars": 32537, "sha256": "46e2f3a7c3f65a498963bae953eda6477c4a41b7a28e0175c548cbe4dc5acc7a", "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2023", "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2023", "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt", "parts": [ { "number": 1, "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html", "chars": 32537 } ] } ], "alternatives": [] } ]